Analyst firms · Morgan Stanley · NTRA
Morgan Stanley NTRA price target and rating history
Natera Inc. (NTRA) · Health Care
Morgan Stanley rates Natera Inc. (NTRA) Overweight with a $265 price target, as of its latest action on Dec 2, 2025. It has published 3 rating actions on NTRA since February 2022, including 0 upgrades and 0 downgrades. Across 8 firms with a NTRA price target in the last 12 months, the median target is $305. Morgan Stanley's $265 is 13% below that.
- Current rating
- Overweight
- Price target
- $265
- Median target, all firms
- $305
- Actions on NTRA
- 3
Morgan Stanley price target on NTRA
Every Morgan Stanley rating on NTRA
- Dec 2, 2025
- Feb 28, 2022
- Feb 15, 2022
How other firms rate NTRA
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Roth Capital | Buy | $475 | Oct 23, 2026 |
| UBS | Buy | $435 | Sep 9, 2026 |
| Rothschild & Co Redburn | Buy | $385 | Sep 8, 2026 |
| Bernstein | Outperform | $310 | Jun 26, 2026 |
| RBC Capital Markets | Outperform | $275 | Jun 12, 2026 |
| Wolfe Research | Outperform | $260 | Jun 2, 2026 |
| William Blair | Outperform | Apr 14, 2026 | |
| Citigroup | Buy | $300 | Jan 7, 2026 |
| Morgan Stanley | Overweight | $265 | Dec 2, 2025 |
Questions about Morgan Stanley and NTRA
- What is Morgan Stanley's price target for NTRA?
- Morgan Stanley's latest stated price target for Natera Inc. (NTRA) is $265, from its action on Dec 2, 2025.
- What is Morgan Stanley's rating on NTRA?
- Morgan Stanley rates NTRA Overweight, a bullish rating, as of Dec 2, 2025.
- When did Morgan Stanley last change its view on NTRA?
- On Dec 2, 2025, Morgan Stanley resumes coverage at Overweight, price target $265.
- How does Morgan Stanley's NTRA target compare with other analysts?
- Across 8 firms with a NTRA price target in the last 12 months, the median target is $305. Morgan Stanley's $265 is 13% below that.
More NTRA rating histories
All Morgan Stanley ratingsNTRA news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.